Prescribed by MCNZ-registered doctors
Wegovy® Pen
Contains Semaglutide (same active ingredient as Ozempic)
Programs from $395/month⁺
Lose up to 20% of your bodyweight^
Includes doctor consult, monthly delivery, dietitian meal plan & progress tracking app
30-day money-back guarantee
Features
Wegovy® medication
Doctor consult
Ongoing support
Free home delivery
Progress tracking app
Patient community
12 week onboarding
total cost from
$395
per/month⁺
$395
Included
Included
Included
Included
Included
Included
Pharmacies
total cost approx
$445
per/month
$365
~$80
per visit
Trusted & loved by over
100,000
people across New Zealand & Australia
We’ve helped Kiwis & Aussies lose over
32,000 kg
and counting...
Women who used Moshy
lost 35%
more weight than those on medication alone*
It takes 2 minutes to get started
Step 1
Check your eligibility
Take our medical screener. It takes about 2 minutes. No payment required.
Step 2
Chat with our practitioner
If eligible, you’ll have a video consult with our practitioner to confirm your treatment. Feel free to ask any questions you have about your new prescription.
Step 3
Get treatment delivered
Once approved, your weight loss medication is shipped discreetly each month to your door. We ship anywhere in NZ for free!
Step 4
Stay supported always
Our care team checks in regularly with you, adjusts your plan if needed, and supports you throughout.
Try Moshy for 30 days
If it's not for you, we'll refund you.
30-day money back guarantee
Get a full refund if you are not satisfied for any reason. T&Cs apply
Wegovy (semaglutide injection 2.4mg) is an unfunded prescription medicine - payment for this medicine and additional doctor or pharmacy fees will be required. Wegovy is used for weight loss and maintenance, in addition to diet and exercise in adults and adolescents (> 12 years) who meet certain BMI criteria. It is used as an addition to standard of care heart disease therapy to reduce the risk of serious heart events in adults with a BMI >27 kg/m2 who have heart disease without established diabetes. Wegovy has risks and benefits. Use strictly as directed. If you experience side effects see your doctor, pharmacist or healthcare professional. Please refer to the Wegovy Consumer Medicines Information available at www.medsafe.govt.nz. Wegovy is a registered trademark of Novo Nordisk A/S, Novo Nordisk Pharmaceuticals Ltd, Auckland.
*Claims are based on internal data involving 9,952 patients over 180 days. Research conducted in collaboration with the University of Melbourne showed a 35% relative difference in weight loss at day 180 between groups (p < 0.001). Individual results may vary.
^In the STEP 1 clinical trial study, eligible participants using semaglutide 2.4 mg, combined with a lower-calorie diet and increased physical activity, lost an average of 15% (up to 20%) of their body weight after 68 weeks. Individual results may vary.
⁺On a commit & save plan of 3-months. T&Cs apply.